UNITED STATES
Securities and Exchange Commission
Washington, D.C. 20549
Form 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended March 31, 2012
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the transition period from ____________ to ____________
Commission file number 1-13412
Hudson Technologies, Inc.
(Exact name of registrant as specified in its charter)
|
New York (State or other jurisdiction of incorporation or organization) |
13-3641539 (I.R.S. Employer Identification No.) |
|
1 Blue Hill Plaza P.O. Box 1541 Pearl River, New York (Address of principal executive offices) |
10965 (Zip Code) |
| Registrant’s telephone number, including area code | (845) 735-6000 |
(Former name, former address, and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes ¨ No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (SECTION 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)
x Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act:
| Large accelerated filer | ¨ | Accelerated filer | ¨ |
| Non-accelerated filer (do not check if a smaller reporting company) | ¨ | Smaller reporting company | x |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes x No
State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:
| Common stock, $0.01 par value | 23,790,455 shares | |
| Class | Outstanding at April 29, 2012 |
Hudson Technologies, Inc.
Index
| Part | Item | Page | |||
| Part I. | Financial Information | ||||
| Item 1 | - Financial Statements | ||||
| - Consolidated Balance Sheets | 3 | ||||
| - Consolidated Income Statements | 4 | ||||
| - Consolidated Statements of Cash Flows | 5 | ||||
| - Notes to the Consolidated Financial Statements | 6 | ||||
| Item 2 | - Management’s Discussion and Analysis of Financial Condition and Results of Operations | 12 | |||
| Item 3 | - Quantitative and Qualitative Disclosures About Market Risk | 16 | |||
| Item 4 | - Controls and Procedures | 16 | |||
| Other Information | |||||
| Part II. | |||||
| Item 1 | - Legal Proceedings | 17 | |||
| Item 2 | - Unregistered Sales of Equity Securities and Use of Proceeds | 17 | |||
| Item 6 | - Exhibits | 17 | |||
| Signatures | 18 | ||||
| 2 |
Part I – FINANCIAL INFORMATION
Item 1-Financial Statements
Hudson Technologies, Inc. and subsidiaries
Consolidated Balance Sheets
(Amounts in thousands, except for share and par value amounts)
| March 31, 2012 | December 31, 2011 | |||||||
| (unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 148 | $ | 3,958 | ||||
| Trade accounts receivable - net of allowance for doubtful accounts of $201 and $200 | 8,884 | 2,453 | ||||||
| Inventories | 16,624 | 17,734 | ||||||
| Prepaid expenses and other current assets | 566 | 611 | ||||||
| Deferred tax assets-current | 1,046 | 0 | ||||||
| Total current assets | 27,268 | 24,756 | ||||||
| Property, plant and equipment, less accumulated depreciation and amortization | 3,482 | 3,441 | ||||||
| Other assets | 116 | 79 | ||||||
| Deferred tax assets | 502 | 3,086 | ||||||
| Intangible assets, less accumulated amortization | 91 | 89 | ||||||
| Total Assets | $ | 31,459 | $ | 31,451 | ||||
| Liabilities and Stockholders' Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable and accrued expenses | $ | 4,524 | $ | 5,227 | ||||
| Accrued payroll | 411 | 703 | ||||||
| Short-term debt and current maturities of long-term debt | 4,830 | 6,361 | ||||||
| Total current liabilities | 9,765 | 12,291 | ||||||
| Long-term debt, less current maturities | 145 | 121 | ||||||
| Total Liabilities | 9,910 | 12,412 | ||||||
| Commitments and contingencies | ||||||||
| Stockholders' equity: | ||||||||
| Preferred stock shares authorized 5,000,000 | ||||||||
| Series A Convertible Preferred stock, $0.01 par value ($100 liquidation preference value); shares authorized 150,000 ; none issued or outstanding | 0 | 0 | ||||||
| Common stock, $0.01 par value; shares authorized 50,000,000; 23,790,455 and 23,783,106 issued and outstanding | 238 | 238 | ||||||
| Additional paid-in capital | 42,870 | 42,869 | ||||||
| Accumulated deficit | (21,559 | ) | (24,068 | ) | ||||
| Total Stockholders' Equity | 21,549 | 19,039 | ||||||
| Total Liabilities and Stockholders' Equity | $ | 31,459 | $ | 31,451 | ||||
See Accompanying Notes to the Consolidated Financial Statements.
| 3 |
Hudson Technologies, Inc. and subsidiaries
Consolidated Income Statements
(unaudited)
(Amounts in thousands, except for share and per share amounts)
| Three month period ended March 31, | |||||||||
| 2012 | 2011 | ||||||||
| Revenues | $ | 14,854 | $ | 13,818 | |||||
| Cost of sales | 8,886 | 10,116 | |||||||
| Gross Profit | 5,968 | 3,702 | |||||||
| Operating expenses: | |||||||||
| Selling and marketing | 681 | 642 | |||||||
| General and administrative | 1,069 | 1,070 | |||||||
| Total operating expenses | 1,750 | 1,712 | |||||||
| Operating income | 4,218 | 1,990 | |||||||
| Other income (expense): | |||||||||
| Interest expense | (171 | ) | (243 | ) | |||||
| Interest income | 0 | 8 | |||||||
| Total other income (expense) | (171 | ) | (235 | ) | |||||
| Income before income taxes | 4,047 | 1,755 | |||||||
| Income tax expense | 1,538 | 667 | |||||||
| Net income | $ | 2,509 | $ | 1,088 | |||||
| Net income per common share – Basic | $ | 0.11 | $ | 0.05 | |||||
| Net income per common share - Diluted | $ | 0.10 | $ | 0.04 | |||||
| Weighted average number of shares outstanding – Basic | 23,785,556 | 23,780,606 | |||||||
| Weighted average number of shares outstanding - Diluted | 25,848,956 | 25,168,947 | |||||||
See Accompanying Notes to the Consolidated Financial Statements.
| 4 |
Hudson Technologies, Inc. and subsidiaries
Consolidated Statements of Cash Flows
Decrease in Cash and Cash Equivalents
(unaudited)
(Amounts in thousands)
| Three month period ended March 31, | |||||||||
| 2012 | 2011 | ||||||||
| Cash flows from operating activities: | |||||||||
| Net income | $ | 2,509 | $ | 1,088 | |||||
| Adjustments to reconcile net income to cash used by operating activities: | |||||||||
| Depreciation and amortization | 127 | 127 | |||||||
| Allowance for doubtful accounts | 1 | 30 | |||||||
| Value of share-based payment arrangements | 0 | 5 | |||||||
| Amortization of deferred finance costs | 0 | 6 | |||||||
| Deferred tax benefit | 1,538 | 667 | |||||||
| Changes in assets and liabilities: | |||||||||
| Trade accounts receivable | (6,431 | ) | (6,548 | ) | |||||
| Inventories | 1,110 | (301 | ) | ||||||
| Prepaid and other assets | 11 | (161 | ) | ||||||
| Accounts payable and accrued expenses | (995 | ) | (430 | ) | |||||
| Cash used by operating activities | (2,130 | ) | (5,517 | ) | |||||
| Cash flows from investing activities: | |||||||||
| Additions to patents | (10 | ) | (10 | ) | |||||
| Additions to property, plant, and equipment | (160 | ) | (75 | ) | |||||
| Investment in joint venture | (3 | ) | 0 | ||||||
| Cash used by investing activities | (173 | ) | (85 | ) | |||||
| Cash flows from financing activities: | |||||||||
| Purchase of common stock equivalents | 0 | (90 | ) | ||||||
| (Repayment) proceeds from short-term debt – net | (1,271 | ) | 5,678 | ||||||
| Proceeds from issuance of long-term debt | 65 | 0 | |||||||
| Repayment of long-term debt | (301 | ) | (178 | ) | |||||
| Cash (used) provided by financing activities | (1,507 | ) | 5,410 | ||||||
| Decrease in cash and cash equivalents | (3,810 | ) | (192 | ) | |||||
| Cash and cash equivalents at beginning of period | 3,958 | 3,926 | |||||||
| Cash and cash equivalents at end of period | $ | 148 | $ | 3,734 | |||||
| Supplemental disclosure of cash flow information: | |||||||||
| Cash paid during period for interest | $ | 171 | $ | 230 | |||||
See Accompanying Notes to the Consolidated Financial Statements.
| 5 |
Hudson Technologies, Inc. and subsidiaries
Notes to the Consolidated Financial Statements
Note 1 - Summary of significant accounting policies
Business
Hudson Technologies, Inc., incorporated under the laws of New York on January 11, 1991, is a refrigerant services company providing innovative solutions to recurring problems within the refrigeration industry. The Company's products and services are primarily used in commercial air conditioning, industrial processing and refrigeration systems, including (i) refrigerant sales, (ii) refrigerant management services consisting primarily of reclamation of refrigerants and (iii) RefrigerantSide® Services performed at a customer's site, consisting of system decontamination to remove moisture, oils and other contaminants. In addition, RefrigerantSide® Services include predictive and diagnostic services for industrial and commercial refrigeration applications, which are designed to predict potential catastrophic problems and identify inefficiencies in an operating system. The Company’s Chiller Chemistry®, Chill Smart®, Fluid Chemistry®, and Performance Optimization are predictive and diagnostic service offerings. As a component of the Company’s products and services, the Company also participates in the generation of carbon offset projects. The Company operates through its wholly-owned subsidiary, Hudson Technologies Company. Unless the context requires otherwise, references to the “Company”, “Hudson”, “we”, “us”, “our”, or similar pronouns refer to Hudson Technologies, Inc. and its subsidiaries.
In preparing the accompanying consolidated financial statements, and in accordance with ASC855-10 “Subsequent Events”, the Company’s management has evaluated subsequent events through the date that the financial statements were filed.
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial statements and with the instructions of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. The financial information included in the quarterly report should be read in conjunction with the Company’s audited financial statements and related notes thereto for the year ended December 31, 2011. Operating results for the three month period ended March 31, 2012 are not necessarily indicative of the results that may be expected for the year ending December 31, 2012.
In the opinion of management, all estimates and adjustments considered necessary for a fair presentation have been included and all such adjustments were normal and recurring.
Consolidation
The consolidated financial statements represent all companies of which Hudson directly or indirectly has majority ownership or otherwise controls. Significant intercompany accounts and transactions have been eliminated. The Company's consolidated financial statements include the accounts of wholly-owned subsidiaries Hudson Holdings, Inc. and Hudson Technologies Company.
Fair value of financial instruments
The carrying values of financial instruments including trade accounts receivable and accounts payable approximate fair value at March 31, 2012 and December 31, 2011, because of the relatively short maturity of these instruments. The carrying value of short-and long-term debt approximates fair value, based upon quoted market rates of similar debt issues, as of March 31, 2012 and December 31, 2011.
Credit risk
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivables are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.
The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.
| 6 |
For the three months ended March 31, 2012, one customer accounted for 14% of the Company’s revenues. For the three months ended March 31, 2011, no one customer accounted for 10% or more of the Company’s revenues.
The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have an adverse effect on the Company's future financial position and results of operations.
Cash and cash equivalents
Temporary investments with original maturities of ninety days or less are included in cash and cash equivalents.
Inventories
Inventories, consisting primarily of refrigerant products available for sale, are stated at the lower of cost, on a first-in first-out basis, or market.
Property, plant, and equipment
Property, plant, and equipment are stated at cost, including internally manufactured equipment. The cost to complete equipment that is under construction is not considered to be material to the Company's financial position. Provision for depreciation is recorded (for financial reporting purposes) using the straight-line method over the useful lives of the respective assets. Leasehold improvements are amortized on a straight-line basis over the shorter of economic life or terms of the respective leases. Costs of maintenance and repairs are charged to expense when incurred.
Due to the specialized nature of the Company's business, it is possible that the Company's estimates of equipment useful life periods may change in the future.
Revenues and cost of sales
Revenues are recorded upon completion of service or product shipment and passage of title to customers in accordance with contractual terms. The Company evaluates each sale to ensure collectability. In addition, each sale is based on an arrangement with the customer and the sales price to the buyer is fixed. License fees are recognized over the period of the license based on the respective performance measurements associated with the license. Royalty revenues are recognized when earned. Cost of sales is recorded based on the cost of products shipped or services performed and related direct operating costs of the Company's facilities. To the extent that the Company charges its customers shipping fees such amounts are included as a component of revenue and the corresponding costs are included as a component of cost of sales.
The Company's revenues are derived from refrigerant and reclamation sales and RefrigerantSide® Services, including license and royalty revenues. The revenues for each of these lines are as follows:
| Three Month Period Ended March 31, (in thousands, unaudited) | 2012 | 2011 | ||||||
| Refrigerant and reclamation sales | $ | 13,662 | $ | 12,763 | ||||
| RefrigerantSide® Services | 1,192 | 1,055 | ||||||
| Total | $ | 14,854 | $ | 13,818 | ||||
Income taxes
The Company utilizes the asset and liability method for recording deferred income taxes, which provides for the establishment of deferred tax asset or liability accounts based on the difference between tax and financial reporting bases of certain assets and liabilities. The tax benefit associated with the Company's net operating loss carry forwards (“NOLs”) is recognized to the extent that the Company is expected to recognize future taxable income. The Company assesses the recoverability of its deferred tax assets based on its expectation that it will recognize future taxable income and adjusts its valuation allowance accordingly. As of March 31, 2012 and December 31, 2011, the net deferred tax asset was $1,548,000 and $3,086,000, respectively.
Certain states either do not allow or limit NOLs and as such the Company will be liable for certain state taxes. To the extent that the Company utilizes its NOLs, it will not pay tax on such income but may be subject to the federal alternative minimum tax. In addition, to the extent that the Company’s net income, if any, exceeds the annual NOL limitation it will pay income taxes based on existing statutory rates. Moreover, as a result of a “change in control”, as defined by the Internal Revenue Service, the Company’s ability to utilize its existing NOLs is subject to certain annual limitations. The Company’s NOLs are subject to annual limitations ranging from $1,300,000 to $2,500,000.
| 7 |
As a result of an Internal Revenue Service audit, the 2006 and prior federal tax years have been closed. The Company operates in many states throughout the United States and, as of March 31, 2012, the various states’ statutes of limitations remain open for tax years subsequent to 2004. The Company recognizes interest and penalties, if any, relating to income taxes as a component of the provision for income taxes.
The Company evaluates uncertain tax positions, if any, by determining if it is more likely than not to be sustained upon examination by the taxing authorities. As of March 31, 2012 and December 31, 2011 the Company had no uncertain tax positions.
Income per common and equivalent shares
If dilutive, common equivalent shares (common shares assuming exercise of options and warrants) utilizing the treasury stock method are considered in the presentation of diluted earnings per share. The reconciliation of shares used to determine net income per share is as follows (dollars in thousands, unaudited):
Three Month Period Ended March 31, | ||||||||
| 2012 | 2011 | |||||||
| Net Income | $ | 2,509 | $ | 1,088 | ||||
| Weighted average number of shares – basic | 23,785,556 | 23,780,606 | ||||||
| Shares underlying warrants | 139,938 | 28,604 | ||||||
| Shares underlying options | 1,923,462 | 1,359,737 | ||||||
| Weighted average number of shares outstanding – diluted | 25,848,956 | 25,168,947 | ||||||
During the three month period ended March 31, 2012 and 2011, certain options and warrants aggregating none and 1,324,375 shares, respectively, have been excluded from the calculation of diluted shares, due to the fact that their effect would be anti-dilutive.
Estimates and risks
The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect reported amounts of certain assets and liabilities, the disclosure of contingent assets and liabilities, and the results of operations during the reporting period. Actual results could differ from these estimates.
The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.
Several of the Company's accounting policies involve significant judgments, uncertainties and estimations. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.
| 8 |
The Company participates in an industry that is highly regulated, changes in which could affect operating results. Currently the Company purchases virgin, hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants and which imposed limitations on the importation of certain virgin HCFC refrigerants. Additionally, effective January 1, 2010, the Act further limited the production of virgin HCFC refrigerants and additional federal regulations were enacted which imposed further limitation and a phase down on the use, production and importation of virgin HCFC refrigerants. As a result of litigation the federal regulations implementing the January 2010 phase down schedule have been vacated. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In January 2012, the Environmental Protection Agency (“EPA”) published a proposed rule, which would further reduce the production of HCFC refrigerants when compared to the reductions established in the January 1, 2010 published rule. The reductions set forth in the proposed rule range from 11 to 47 percent from the levels established in the prior rule, for calendar years 2012, 2013, and 2014. The proposed rule is not final and in the interim the EPA has provided allowance holders with no action assurance letters, which permits allowance holders to import or produce up to an amount that equals 55% of the amount each allowance holder could import or produce in 2011.
To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants, the Company could realize reductions in refrigerant processing and possible loss of revenues, which would have a material adverse affect on operating results.
The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which would have a material adverse effect on operating results and its financial position.
Impairment of long-lived assets
The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less the cost to sell.
Note 2 - Share-based compensation
Share-based compensation represents the cost related to share-based awards, typically stock options, granted to employees, non-employees, officers and directors. Share-based compensation is measured at grant date, based on the estimated aggregate fair value of the award on the grant date, and such amount is charged to compensation expense on a straight-line basis (net of estimated forfeitures) over the requisite service period. For the three month period ended March 31, 2012 and 2011, the share-based compensation expense of none and $5,000, respectively, is reflected in general and administrative expenses in the consolidated statements of operations.
Share-based awards have historically been stock options issued pursuant to the terms of the Company’s 1994 and 1997 stock option plans and the Company’s 2004 and 2008 stock incentive plans, (collectively, the “Plans”), described below. The Plans may be administered by the Board of Directors or the Compensation and Stock Option Committee of the Board or by another committee appointed by the Board from among its members as provided in the Plans. Presently, the Plans are administered by a committee consisting of non-employee directors. As of March 31, 2012, the Plans authorized the issuance of stock options to purchase 5,500,000 shares of the Company’s common stock and, as of March 31, 2012 there were 2,659,000 shares of the Company’s common stock available for issuance for future stock option grants or other stock based awards.
Stock option awards, which allow the recipient to purchase shares of the Company’s common stock at a fixed price, are typically granted at an exercise price equal to the Company’s stock price at the date of grant. Typically, the Company’s stock option awards have generally vested from immediately to two years from the grant date and have had a contractual term ranging from five to ten years.
For the three months ended March 31, 2012 and 2011, the Company granted no options. As of March 31, 2012, there was no unrecognized compensation cost related to non-vested previously granted option awards.
Effective October 31, 1994, the Company adopted an Employee Stock Option Plan (“1994 Plan”) pursuant to which 725,000 shares of common stock were reserved for issuance upon the exercise of options designated as either (i) options intended to constitute incentive stock options (“ISOs”) under the Internal Revenue Code of 1986, as amended, (“Code”) or (ii) nonqualified options. ISOs could be granted under the 1994 Plan to employees and officers of the Company. Non-qualified options could be granted to consultants, directors (whether or not they are employees), employees or officers of the Company. Effective November 1, 2004, the Company’s ability to grant options under the 1994 Plan expired.
| 9 |
Effective July 25, 1997, the Company adopted its 1997 Employee Stock Option Plan, which was amended on August 19, 1999, (“1997 Plan”) pursuant to which 2,000,000 shares of common stock were reserved for issuance upon the exercise of options designated as either (i) ISOs under the Code, or (ii) nonqualified options. ISOs could be granted under the 1997 Plan to employees and officers of the Company. Non-qualified options could be granted to consultants, directors (whether or not they are employees), employees or officers of the Company. Stock appreciation rights could also be issued in tandem with stock options. Effective June 11, 2007, the Company’s ability to grant options or stock appreciation rights under the 1997 Plan expired.
Effective September 10, 2004, the Company adopted its 2004 Stock Incentive Plan (“2004 Plan”) pursuant to which 2,500,000 shares of common stock were reserved for issuance upon the exercise of options, designated as either (i) ISOs under the Code, or (ii) nonqualified options, restricted stock, deferred stock or other stock-based awards. ISOs may be granted under the 2004 Plan to employees and officers of the Company. Non qualified options, restricted stock, deferred stock or other stock-based awards may be granted to consultants, directors (whether or not they are employees), employees or officers of the Company. Stock appreciation rights may also be issued in tandem with stock options. Unless the 2004 Plan is sooner terminated, the ability to grant options or other awards under the 2004 Plan will expire on September 10, 2014.
ISOs granted under the 2004 Plan may not be granted at a price less than the fair market value of the common stock on the date of grant (or 110% of fair market value in the case of persons holding 10% or more of the voting stock of the Company). Nonqualified options granted under the 2004 Plan may not be granted at a price less than the fair market value of the common stock. Options granted under the 2004 Plan expire not more than ten years from the date of grant (five years in the case of ISOs granted to persons holding 10% or more of the voting stock of the Company).
Effective August 27, 2008, the Company adopted its 2008 Stock Incentive Plan (“2008 Plan”) pursuant to which 3,000,000 shares of common stock were reserved for issuance upon the exercise of options, designated as either (i) ISOs under the Code, or (ii) nonqualified options, restricted stock, deferred stock or other stock-based awards. ISOs may be granted under the 2008 Plan to employees and officers of the Company. Non qualified options, restricted stock, deferred stock or other stock-based awards may be granted to consultants, directors (whether or not they are employees), employees or officers of the Company. Stock appreciation rights may also be issued in tandem with stock options. Unless the 2008 Plan is sooner terminated, the ability to grant options or other awards under the 2008 Plan will expire on August 27, 2018.
ISOs granted under the 2008 Plan may not be granted at a price less than the fair market value of the common stock on the date of grant (or 110% of fair market value in the case of persons holding 10% or more of the voting stock of the Company). Nonqualified options granted under the 2008 Plan may not be granted at a price less than the fair market value of the common stock. Options granted under the 2008 Plan expire not more than ten years from the date of grant (five years in the case of ISOs granted to persons holding 10% or more of the voting stock of the Company).
All stock options have been granted to employees and non-employees at exercise prices equal to or in excess of the market value on the date of the grant.
The Company determines the fair value of share based awards at the grant date by using the Black-Scholes option-pricing model, and is incorporating the simplified method to compute expected lives of share based awards with the following weighted-average assumptions:
| Three Month Period Ended March 31, | 2012 | 2011 | ||||||
| Assumptions | ||||||||
| Dividend Yield | - | 0 | % | |||||
| Risk free interest rate | - | 2.5 | % | |||||
| Expected volatility | - | 56 | % | |||||
| Expected lives | - | 2 to 5 years | ||||||
| 10 |
A summary of the activity for the Company's Plans for the indicated periods is presented below:
| Stock Option Plan Totals | Shares | Weighted Average Exercise Price | ||||||
| Outstanding at December 31, 2010 | 3,411,943 | $ | 1.23 | |||||
| · Cancelled | (49,000 | ) | $ | 2.04 | ||||
| · Exercised | (2,500 | ) | $ | 1.12 | ||||
| · Granted | 75,000 | $ | 1.31 | |||||
| Outstanding at December 31, 2011 and March 31, 2012 | 3,435,443 | $ | 1.22 | |||||
The following is the weighted average contractual life in years and the weighted average exercise price at March 31, 2012 of:
| Weighted Average | ||||||||||
| Number of | Remaining | Weighted Average | ||||||||
| Options | Contractual Life | Exercise Price | ||||||||
| Options outstanding | 3,435,443 | 5.8 years | $ | 1.22 | ||||||
| Options vested | 3,427,943 | 5.8 years | $ | 1.22 | ||||||
The following is the intrinsic value at March 31, 2012 of:
| Options outstanding | $ | 4,542,118 | ||
| Options vested in 2012 | 0 | |||
| Options exercised in 2012 | 0 |
The intrinsic value of options exercised during the year ended December 31, 2011 was $700.
Note 3 - Debt
On June 26, 2007, a subsidiary of Hudson entered into a credit facility (the “Facility”) with Keltic Financial Partners, LP (“Keltic”), and on April 17, 2008 the Facility was amended to secure the participation of Bridge Healthcare Financial, LLC (“Bridge”) and to provide for borrowings of up to $15,000,000. On September 23, 2009, Keltic advised the Company that it has assumed all of Bridge’s rights under the Facility. The Facility consists of a revolving line of credit and two term loans, and expires on June 26, 2012. Advances under the revolving line of credit are limited to (i) 85% of eligible trade accounts receivable and (ii) 55% of eligible inventory. Advances available to Hudson under the A and B term loans may not exceed $2,500,000 and $4,500,000, respectively. At March 31, 2012, the Facility bore interest at 6.5%. Substantially all of Hudson's assets are pledged as collateral for its obligations under the Facility. In addition, among other things, the Facility restricts Hudson's ability to declare or pay any cash dividends on its capital stock. As of March 31, 2012, Hudson had in the aggregate $1,573,000 of borrowings outstanding and $8,677,000 available for borrowing under the revolving line of credit. In addition, as of March 31, 2012, the Company had $2,250,000 of borrowings outstanding under the A and B term loans and all such amounts are included as current debt due to the Facility’s expiration date in June 2012. The Company is seeking to renew and possibly increase its existing Facility but there can be no assurance that the Company will be successful.
In connection with the April 2008 amendment to the Facility, the Company issued 100,000 five-year common stock purchase warrants exercisable at $1.88 per share. The Company utilizes the Black-Scholes pricing model to compute the fair value of the 100,000 stock purchase warrants. The fair value of the warrants was $74,000 and has been fully amortized.
Note 4- Investment In Unconsolidated Subsidiary
In July 2011, the Company entered into a joint venture agreement with Safety Hi-Tech S.r.l (“SHT”) and with the principals of Banini-Binotti Associates (“BB”). The joint venture has created a new entity known as Hudson Technologies Europe, S.r.l. (“HTE”). The Company and SHT each own 40% of HTE and BB owns the remaining 20%. HTE’s purpose is to develop a business that provides for refrigerant reclamation, RefrigerantSide® services and energy optimization services throughout Europe, the Middle East and North Africa. As of March 31, 2012 the joint venture has not begun operations. In 2012, the Company’s share of the joint venture will be recorded under the equity method.
| 11 |
Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations
Certain statements contained in this section and elsewhere in this Form 10-Q constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changes in the demand and price for refrigerants (including unfavorable market conditions adversely affecting the demand for, and the price of refrigerants), the Company's ability to source CFC and non-CFC based refrigerants, regulatory and economic factors, seasonality, competition, litigation, the nature of supplier or customer arrangements that become available to the Company in the future, adverse weather conditions, possible technological obsolescence of existing products and services, possible reduction in the carrying value of long-lived assets, estimates of the useful life of its assets, potential environmental liability, customer concentration, the ability to obtain financing, and other risks detailed in this report and in the Company's other periodic reports filed with the Securities and Exchange Commission (“SEC”). The words “believe”, “expect”, “anticipate”, “may”, “plan”, “should” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.
Critical Accounting Policies
The Company's discussion and analysis of its financial condition and results of operations are based upon its consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities. Several of the Company's accounting policies involve significant judgments, uncertainties and estimations. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its net operating loss carry forwards (“NOLs”) and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.
Overview
Sales of refrigerants continue to represent a significant portion of the Company’s revenues. The Company’s refrigerant sales are primarily HCFC and HFC based refrigerants and to a lesser extent CFC based refrigerants that are no longer manufactured. Under the Act the phase-down of future production of certain virgin HCFC refrigerants commenced in 2010 and is scheduled to be phased out by the year 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by the year 2030.
The Company has created and developed a service offering known as RefrigerantSide® Services. RefrigerantSide® Services are sold to contractors and end-users whose refrigeration systems are used in commercial air conditioning and industrial processing. These services are offered in addition to refrigerant sales and the Company's traditional refrigerant management services, which consist primarily of reclamation of refrigerants. The Company has created a network of service depots that provide a full range of the Company's RefrigerantSide® Services to facilitate the growth and development of its service offerings.
The Company focuses its sales and marketing efforts for its RefrigerantSide® Services on customers who the Company believes most readily appreciate and understand the value that is provided by its RefrigerantSide® Services offering. In pursuing its sales and marketing strategy, the Company offers its RefrigerantSide® Services to customers in the following industries: petrochemical, pharmaceutical, industrial power, manufacturing, commercial facility and property management and maritime. The Company may incur additional expenses as it develops its RefrigerantSide® Services offering.
| 12 |
Results of Operations
Three month period ended March 31, 2012 as compared to the three month period ended March 31, 2011
Revenues for the three month period ended March 31, 2012 were $14,854,000, an increase of $1,036,000 or 7% from the $13,818,000 reported during the comparable 2011 period. The increase in revenues was primarily attributable to an increase in refrigerant revenues of $899,000 and an increase in RefrigerantSide® Services revenues of $137,000. The increase in refrigerant revenues is primarily related to an increase in the average selling price per pound of certain refrigerant sold offset in part by a decrease in the number of pounds sold. The increase in RefrigerantSide® Services was primarily related to an increase in the average price of the jobs completed when compared to the same period of 2011.
Cost of sales for the three month period ended March 31, 2012 was $8,886,000, a decrease of $1,230,000 or 12% from the $10,116,000 reported during the comparable 2011 period. The decrease in cost of sales was primarily due to the decrease in the number of pounds of refrigerant sold in the 2012 period. As a percentage of sales, cost of sales was 60% of revenues for 2012, a decrease from the 73% reported for the comparable 2011 period, primarily due to a higher average selling price per pound for certain refrigerants in 2012 as compared to the comparable 2011 period.
Operating expenses for the three month period ended March 31, 2012 were $1,750,000 an increase of $38,000 or 2% from the $1,712,000 reported during the comparable 2011 period. The increase in operating expenses was primarily related to an increase in selling expenses.
Other income (expense) for the three month period ended March 31, 2012 was ($171,000), compared to the ($235,000) reported during the comparable 2011 period. Other income (expense) includes interest expense of $171,000 and $243,000 for the comparable 2012 and 2011 periods, respectively. The decrease in interest expense is due to a reduction in average outstanding borrowings in 2012 when compared to 2011.
Income tax expense for the three month period ended March 31, 2012 and 2011 was $1,538,000 and $667,000, respectively. For 2012, the income tax provision of $1,538,000 was for federal and state income tax at statutory rates. The tax benefits associated with the Company’s NOLs are recognized to the extent that the Company is expected to recognize taxable income in future periods. The Company’s NOLs are subject to annual limitations and the Company expects to incur certain state and/or federal alternative minimum taxes for the foreseeable future.
Net income for the three month period ended March 31, 2012 was $2,509,000, an increase of $1,421,000 from the $1,088,000 net income reported during the comparable 2011 period, primarily due to increased revenues and gross profit, partially offset by increased operating expenses.
Liquidity and Capital Resources
At March 31, 2012, the Company had working capital, which represents current assets less current liabilities of $17,503,000, an increase of $5,038,000 from the working capital of $12,465,000 at December 31, 2011. The increase in working capital is primarily attributable to net income for the period and the reclassification of $1,046,000 from deferred tax assets, non-current to current, and the utilization of $1,538,000 of the deferred tax asset.
Inventory and trade receivables are principal components of current assets. At March 31, 2012, the Company had inventories of $16,624,000, a decrease of $1,110,000 from $17,734,000 at December 31, 2011. The decrease in the inventory balance is due to the timing and availability of inventory purchases and the sale of refrigerants. The Company's ability to sell and replace its inventory on a timely basis and the prices at which it can be sold are subject, among other things, to current market conditions and the nature of supplier or customer arrangements and the Company's ability to source CFC based refrigerants, which are no longer being manufactured, or non-CFC based refrigerants. At March 31, 2012, the Company had trade receivables, net of allowance for doubtful accounts of $8,884,000, an increase of $6,431,000 from $2,453,000 at December 31, 2011. The Company's trade receivables are concentrated with various wholesalers, brokers, contractors and end-users within the refrigeration industry that are primarily located in the continental United States.
The Company has historically financed its working capital requirements through cash flows from operations, the issuance of debt and equity securities, and bank borrowings.
| 13 |
Net cash used by operating activities for the three month period ended March 31, 2012, was $2,130,000 compared with net cash used by operating activities of $5,517,000 for the comparable 2011 period. Net cash used by operating activities for the 2012 period was primarily attributable to net income after adjustments for non-cash expenses, and a decrease in inventory, offset by an increase in accounts receivable and a decrease in accounts payable.
Net cash used by investing activities for the three month period ended March 31, 2012, was $173,000 compared with net cash used by investing activities of $85,000 for the comparable 2011 period. The net cash used by investing activities for the 2012 period was primarily related to investment in general purpose equipment for the Company’s Champaign, Illinois facility, as well as equipment for its investment in HTE.
Net cash used by financing activities for the three month period ended March 31, 2012, was $1,507,000 compared with net cash provided by financing activities of $5,410,000 for the comparable 2011 period. The net cash used by financing activities for the 2012 period was primarily due to repayment of short term debt.
At March 31, 2012, the Company had cash and cash equivalents of $148,000. The Company continues to assess its capital expenditure needs. The Company may, to the extent necessary, continue to utilize its cash balances to purchase equipment primarily for its operations. The Company estimates that the total capital expenditures for 2012 will be approximately $650,000.
The following is a summary of the Company's significant contractual cash obligations for the periods indicated that existed as of March 31, 2012 (in 000’s):
| Twelve Month Period Ended March 31, | ||||||||||||||||||||
| 2013 | 2014 | 2015 | 2016 | Total | ||||||||||||||||
| Long and short term debt and capital lease obligations: | ||||||||||||||||||||
| Principal | $ | 4,830 | $ | 59 | $ | 45 | $ | 41 | $ | 4,975 | ||||||||||
| Estimated interest (1) (2) | 195 | 5 | 3 | 1 | 204 | |||||||||||||||
| Operating leases | 614 | 353 | 294 | 145 | 1,406 | |||||||||||||||
| Total contractual cash obligations | $ | 5,639 | $ | 417 | $ | 342 | $ | 187 | $ | 6,585 | ||||||||||
____________
(1) The estimated interest payments on revolving debt are based on the interest rates in effect and the outstanding revolving debt obligation as of March 31, 2012 through the expiration of the Company’s credit facility on June 26, 2012.
(2) The estimated future interest payments on all debt other than revolving debt are based on the respective interest rates applied to the declining principal balances on each of the notes.
On June 26, 2007, a subsidiary of Hudson entered into the Facility with Keltic, and on April 17, 2008 the Facility was amended to secure the participation of Bridge and to provide for borrowings of up to $15,000,000. On September 23, 2009, Keltic advised the Company that it had assumed all of Bridge’s rights under the Facility. On April 19, 2011 the Company amended the Facility with Keltic extending the Facility to June 26, 2012. The Facility consists of a revolving line of credit and two term loans, and expires on June 26, 2012. Advances under the revolving line of credit are limited to (i) 85% of eligible trade accounts receivable and (ii) 55% of eligible inventory. Advances available to Hudson under the A and B term loans may not exceed $2,500,000 and $4,500,000, respectively. At March 31, 2012, the Facility bore interest at 6.5%. Substantially all of Hudson's assets are pledged as collateral for its obligations under the Facility. In addition, among other things, the Facility restricts Hudson's ability to declare or pay any cash dividends on its capital stock. As of March 31, 2012, Hudson had $1,573,000 of borrowings outstanding and $8,677,000 available for borrowing under the revolving line of credit. In addition, as of March 31, 2012, Hudson had $2,250,000 of borrowings outstanding under the A and B term loans.
In connection with the April 2008 amendment to the Facility, the Company issued an aggregate of 100,000 five-year common stock purchase warrants exercisable at $1.88 per share.
The Facility contains three financial covenants: (a) minimum earnings before interest, taxes, depreciation and amortization (“EBITDA”); (b) minimum tangible net worth; and (c) maximum capital expenditures.
| (a) | EBITDA, which represents a non-GAAP measurement of certain financial results, is defined in the Facility as total income before interest expense, taxes, depreciation, amortization, and other non-cash expenses (“Adjusted EBITDA”). The Adjusted EBITDA is calculated quarterly on a rolling twelve months basis. |
| (b) | Tangible net worth is calculated quarterly and is defined as total assets less intangible assets, less total liabilities. |
| (c) | Capital expenditures are compared quarterly on a year to date basis to an annual cap set forth in the Facility. |
| 14 |
On April 28, 2010, the Facility was amended, which amendment, among other things, reset the Adjusted EBITDA covenant, which is set at $1,781,000 through the term of the Facility.
As of March 31, 2012, the Company was in compliance with all covenants in the Facility. The Company believes that it is reasonably likely that in the foreseeable future, the Company will continue to be in compliance with all covenants in the Facility.
On July 7, 2010, the Company sold 2,737,500 units, with the aggregate units consisting of 2,737,500 shares of the Company’s common stock and warrants to purchase 1,368,750 shares, at a price of $2.00 per unit pursuant to the Company’s shelf registration and received net proceeds of approximately $4,900,000 (“2010 Offering”). The warrants issued as part of the 2010 Offering have an exercise price of $2.60 per share and were initially exercisable for a five-year period. Effective as of March 4, 2011, the Company repurchased warrants to purchase 150,000 shares of the Company’s common stock, at a price of $0.60 per warrant. In March 2011 the expiration date of the remaining warrants was extended to July 7, 2016. The value of the aggregate number of warrants issued pursuant to the 2010 Offering was approximately $1,300,000 and such amount was charged as a component of stockholders’ equity to additional paid in capital. In March 2012 warrants to purchase 50,000 shares of the Company’s common stock were exercised on a “net exercise” basis and the Company issued 7,349 shares of common stock in exchange for the warrants surrendered. As a result of the repurchase, and the exercise of 50,000 warrants, there are 1,168,750 warrants outstanding.
In May 2005, the Company purchased its Champaign, Illinois facility for a total purchase price of $999,999. The Company financed the purchase with a loan in the amount of $945,000 with a balloon payment of $636,000 due on June 1, 2012. The note bears interest at 5.25%.
In April 2008, the Company purchased approximately five acres of vacant land adjacent to its Champaign, Illinois facility for $300,000. The Company financed the purchase with a loan in the amount of $300,000 with a balloon payment of $248,000 due on June 1, 2012. The note bears interest at the fixed rate of 6.7%.
The Company believes that it will be able to satisfy its working capital requirements for the foreseeable future from anticipated cash flows from operations and available funds under the Facility. The Company’s Facility will expire in June 2012. Although the Company is seeking to renew and possibly increase the existing Facility, there can be no assurance that it will be successful. Any unanticipated expenses, including, but not limited to, an increase in the cost of refrigerants purchased by the Company, an increase in operating expenses or failure to achieve expected revenues from the Company's RefrigerantSide® Services and/or refrigerant sales or additional expansion or acquisition costs that may arise in the future or, to the extent that the Company does not renew or replace the Facility when it expires, would adversely affect the Company's future capital needs. There can be no assurance that the Company's proposed or future plans will be successful, and as such, the Company may require additional capital sooner than anticipated, which capital may not be available.
Inflation
Inflation has not historically had a material impact on the Company's operations.
Reliance on Suppliers and Customers
The Company's financial performance and its ability to sell refrigerants is in part dependent on its ability to obtain sufficient quantities of virgin, non-CFC based refrigerants, and of reclaimable CFC and non-CFC based, refrigerants from manufacturers, wholesalers, distributors, bulk gas brokers and from other sources within the air conditioning, refrigeration and automotive aftermarket industries, and on corresponding demand for refrigerants. The Company's refrigerant sales include CFC based refrigerants, which are no longer manufactured. Additionally, the Company's refrigerant sales include non-CFC based refrigerants, including HCFC and HFC refrigerants, which are the most widely used refrigerants. Effective January 1, 1996, the Act limits the production of virgin HCFC refrigerants, which production was further limited in January 2004. Federal regulations enacted in January 2004 established production and consumption allowances for HCFCs and imposed limitations on the importation of certain virgin HCFC refrigerants. Additionally, effective January 2010, the Act further limited the production of virgin HCFC refrigerants and additional federal regulations were enacted which imposed further limitations and a phase down on the use, production and importation of certain virgin HCFC refrigerants. As a result of certain litigation, the federal regulations implementing the January 2010 phase down schedule have been vacated and in July 2011 the EPA recast production and consumption allowances for the 2011 year. In January 2012, the EPA published a proposed rule, which would further reduce the production of HCFC refrigerants when compared to the reductions established in the January 1, 2010 published rule. The reductions set forth in the proposed rule range from 11 to 47 percent from the levels established in the prior rule, for calendar years 2012, 2013, and 2014. The proposed rule is not final and in the interim the EPA has provided allowance holders with no action assurance letters, which permits allowance holders to import or produce up to an amount that equals 55% of the amount each allowance holder could import or produce in 2011. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out by the year 2020 and production of all virgin HCFC refrigerants is scheduled to be phased out by the year 2030. The limitations imposed by and under the Act may limit supplies of virgin refrigerants for the foreseeable future or cause a significant increase in the price of virgin HCFC refrigerants.
| 15 |
For the three months ended March 31, 2012, one customer accounted for 14% of the Company’s revenues. For the three months ended March 31, 2011, no one customer accounted for 10% or more of the Company’s revenues.
The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have a material adverse effect on the Company's financial position and results of operations.
Seasonality and Weather Conditions and Fluctuations in Operating Results
The Company's operating results vary from period to period as a result of weather conditions, requirements of potential customers, non-recurring refrigerant and service sales, availability and price of refrigerant products (virgin or reclaimable), changes in reclamation technology and regulations, timing in introduction and/or retrofit or replacement of CFC and non CFC based refrigeration equipment, the rate of expansion of the Company's operations, and by other factors. The Company's business is seasonal in nature with peak sales of refrigerants occurring in the first half of each year. During past years, the seasonal decrease in sales of refrigerants has resulted in losses particularly in the fourth quarter of the year. In addition, to the extent that there is unseasonably cool weather throughout the spring and summer months, which would adversely affect the demand for refrigerants; there would be a corresponding negative impact on the Company. Delays or inability in securing adequate supplies of refrigerants at peak demand periods, lack of refrigerant demand, increased expenses, declining refrigerant prices and a loss of a principal customer could result in significant losses. There can be no assurance that the foregoing factors will not occur and result in a material adverse effect on the Company's financial position and significant losses. The Company believes that there is a similar seasonal element to RefrigerantSide® Service revenues as refrigerant sales. The Company is continuing to assess its RefrigerantSide® Service revenues seasonal trend.
Item 3 - Quantitative and Qualitative Disclosures about Market Risk
Not Applicable
Item 4 - Controls and Procedures
Disclosure Controls and Procedures
The Company, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures, as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that the Company’s disclosure controls and procedures provide reasonable assurance that they are effective to ensure that information required to be disclosed in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and that such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. Because of the inherent limitations in all control systems, any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Furthermore, the Company’s controls and procedures can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the control and misstatements due to error or fraud may occur and not be detected on a timely basis.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) in the quarter ended March 31, 2012 that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
| 16 |
PART II – OTHER INFORMATION
Item 1 - Legal Proceedings
For information regarding pending legal matters, refer to the Legal Proceedings Section in Part I, Item 3 of the Company’s Form 10-K for the year ended December 31, 2011.
Item 2- Unregistered Sales of Equity Securities and Use of Proceeds
On March 13, 2012, the Company issued 7,349 shares of common stock upon the cashless exercise of outstanding warrants, based upon a fair market valuation of $3.048 per share on the exercise date (as calculated under the warrants), The Company did not receive any cash proceeds upon the exercise of the warrants. Issuance of the shares of common stock was exempt from registration pursuant to the provisions of Section 3(a) (9) of the Securities Act of 1933. There have been no other unregistered sales of securities during the period covered by this Quarterly Report on Form 10-Q.
Item 6 - Exhibits
The following exhibits are attached to this report:
| 31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101 | Interactive Data Files Pursuant to Rule 405 of Regulation S-T |
| 17 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
HUDSON TECHNOLOGIES, INC.
| By: | /s/ Kevin J. Zugibe | May 1, 2012 | ||
| Kevin J. Zugibe | Date | |||
| Chairman and | ||||
| Chief Executive Officer |
| By: | /s/ James R. Buscemi | May 1, 2012 | ||
| James R. Buscemi | Date | |||
| Chief Financial Officer |
| 18 |
Index to Exhibits
| Exhibit Number |
Description | |
| Exhibits | ||
| 31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 32.2 | Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
| 101 | Interactive Data Files Pursuant to Rule 405 of Regulation S-T |
| 19 |